FMR4: A New RNA Linked to Fragile X Syndrome
Author Information
Author(s): Khalil Ahmad M. Faghihi, Mohammad Ali Modarresi, Farzaneh Brothers, Shaun P. Wahlestedt, Claes Wahlestedt
Primary Institution: The Scripps Research Institute
Hypothesis
Does the noncoding RNA FMR4 have an antiapoptotic function and is it affected by the CGG expansion in the FMR1 gene associated with fragile X syndrome?
Conclusion
FMR4 has an antiapoptotic function and is silenced in fragile X syndrome, suggesting its potential role in the disease's clinical presentation.
Supporting Evidence
- FMR4 is expressed in several human adult tissues including the brain, liver, and heart.
- Knockdown of FMR4 led to increased apoptosis in human cells.
- FMR4 expression is silenced in full mutation fragile X patients.
Takeaway
Scientists found a new RNA called FMR4 that helps cells stay alive, and it doesn't work properly in people with fragile X syndrome.
Methodology
The study used genomic approaches including RT-PCR and siRNA knockdown experiments to analyze FMR4 expression and function.
Potential Biases
Potential bias in sample selection and the focus on specific tissues may affect the generalizability of the findings.
Limitations
The study primarily focused on human and monkey tissues, limiting the understanding of FMR4's role in other species.
Participant Demographics
The study included samples from normal individuals, premutation carriers, and full mutation fragile X patients.
Statistical Information
P-Value
p<0.0001
Statistical Significance
p<0.0001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website